225 related articles for article (PubMed ID: 21625575)
1. Protective efficacy of serially up-ranked subdominant CD8+ T cell epitopes against virus challenges.
Im EJ; Hong JP; Roshorm Y; Bridgeman A; Létourneau S; Liljeström P; Potash MJ; Volsky DJ; McMichael AJ; Hanke T
PLoS Pathog; 2011 May; 7(5):e1002041. PubMed ID: 21625575
[TBL] [Abstract][Full Text] [Related]
2. Immunodominance in virus-induced CD8(+) T-cell responses is dramatically modified by DNA immunization and is regulated by gamma interferon.
Rodriguez F; Harkins S; Slifka MK; Whitton JL
J Virol; 2002 May; 76(9):4251-9. PubMed ID: 11932390
[TBL] [Abstract][Full Text] [Related]
3. Responses against a subdominant CD8+ T cell epitope protect against immunopathology caused by a dominant epitope.
Ruckwardt TJ; Luongo C; Malloy AM; Liu J; Chen M; Collins PL; Graham BS
J Immunol; 2010 Oct; 185(8):4673-80. PubMed ID: 20833834
[TBL] [Abstract][Full Text] [Related]
4. Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines.
Borthwick N; Lin Z; Akahoshi T; Llano A; Silva-Arrieta S; Ahmed T; Dorrell L; Brander C; Murakoshi H; Takiguchi M; Hanke T
PLoS One; 2017; 12(4):e0176418. PubMed ID: 28448594
[TBL] [Abstract][Full Text] [Related]
5. Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine.
Schwerdtfeger M; Andersson AC; Neukirch L; Holst PJ
J Transl Med; 2019 May; 17(1):175. PubMed ID: 31126293
[TBL] [Abstract][Full Text] [Related]
6. Subdominant/cryptic CD8 T cell epitopes contribute to resistance against experimental infection with a human protozoan parasite.
Dominguez MR; Silveira EL; de Vasconcelos JR; de Alencar BC; Machado AV; Bruna-Romero O; Gazzinelli RT; Rodrigues MM
PLoS One; 2011; 6(7):e22011. PubMed ID: 21779365
[TBL] [Abstract][Full Text] [Related]
7. Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses.
Hancock G; Yang H; Yorke E; Wainwright E; Bourne V; Frisbee A; Payne TL; Berrong M; Ferrari G; Chopera D; Hanke T; Mothe B; Brander C; McElrath MJ; McMichael A; Goonetilleke N; Tomaras GD; Frahm N; Dorrell L
PLoS Pathog; 2015 Feb; 11(2):e1004658. PubMed ID: 25723536
[TBL] [Abstract][Full Text] [Related]
8. Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity.
Eickhoff CS; Zhang X; Vasconcelos JR; Motz RG; Sullivan NL; O'Shea K; Pozzi N; Gohara DW; Blase JR; Di Cera E; Hoft DF
PLoS Pathog; 2016 Sep; 12(9):e1005896. PubMed ID: 27642757
[TBL] [Abstract][Full Text] [Related]
9. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
[TBL] [Abstract][Full Text] [Related]
10. Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies.
Liu J; Ewald BA; Lynch DM; Nanda A; Sumida SM; Barouch DH
J Virol; 2006 Dec; 80(24):11991-7. PubMed ID: 17005652
[TBL] [Abstract][Full Text] [Related]
11. Preferential escape of subdominant CD8+ T cells during negative selection results in an altered antiviral T cell hierarchy.
Slifka MK; Blattman JN; Sourdive DJ; Liu F; Huffman DL; Wolfe T; Hughes A; Oldstone MB; Ahmed R; Von Herrath MG
J Immunol; 2003 Feb; 170(3):1231-9. PubMed ID: 12538681
[TBL] [Abstract][Full Text] [Related]
12. Repertoire and immunofocusing of CD8 T cell responses generated by HIV-1 gag-pol and expression library immunization vaccines.
Singh RA; Barry MA
J Immunol; 2004 Oct; 173(7):4387-93. PubMed ID: 15383568
[TBL] [Abstract][Full Text] [Related]
13. Silencing an immunodominant epitope of hepatitis B surface antigen reveals an alternative repertoire of CD8 T cell epitopes of this viral antigen.
Wieland A; Riedl P; Reimann J; Schirmbeck R
Vaccine; 2009 Dec; 28(1):114-9. PubMed ID: 19818719
[TBL] [Abstract][Full Text] [Related]
14. Conserved HIV-1 epitopes continuously elicit subdominant cytotoxic T-lymphocyte responses.
Liu Y; McNevin J; Rolland M; Zhao H; Deng W; Maenza J; Stevens CE; Collier AC; McElrath MJ; Mullins JI
J Infect Dis; 2009 Dec; 200(12):1825-33. PubMed ID: 19909083
[TBL] [Abstract][Full Text] [Related]
15. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
[TBL] [Abstract][Full Text] [Related]
16. DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4⁺ T cells, but few subdominant epitope-specific CD8⁺ T cells.
Vojnov L; Bean AT; Peterson EJ; Chiuchiolo MJ; Sacha JB; Denes FS; Sandor M; Fuller DH; Fuller JT; Parks CL; McDermott AB; Wilson NA; Watkins DI
Vaccine; 2011 Oct; 29(43):7483-90. PubMed ID: 21839132
[TBL] [Abstract][Full Text] [Related]
17. Immunization with dendritic cells breaks immunodominance in CTL responses against minor histocompatibility and synthetic peptide antigens.
Grufman P; Sandberg JK; Wolpert EZ; Kärre K
J Leukoc Biol; 1999 Aug; 66(2):268-71. PubMed ID: 10449165
[TBL] [Abstract][Full Text] [Related]
18. Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulation.
van der Most RG; Murali-Krishna K; Lanier JG; Wherry EJ; Puglielli MT; Blattman JN; Sette A; Ahmed R
Virology; 2003 Oct; 315(1):93-102. PubMed ID: 14592762
[TBL] [Abstract][Full Text] [Related]
19. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
Riedl P; Wieland A; Lamberth K; Buus S; Lemonnier F; Reifenberg K; Reimann J; Schirmbeck R
J Immunol; 2009 Jul; 183(1):370-80. PubMed ID: 19542448
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of the CD8+ T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope.
Mok H; Lee S; Wright DW; Crowe JE
Vaccine; 2008 Sep; 26(37):4775-82. PubMed ID: 18662734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
